Literature DB >> 781898

Relation of alpha-1-antitrypsin phenotype to the performance of pulmonary function tests and to the prevalence of respiratory illness in a working population.

R B Cole, N C Nevin, G Blundell, J D Merrett, J R McDonald, W P Johnston.   

Abstract

Individuals with severe alpha-1-antitrypsin (alpha1AT) deficiency (phenotype Pi ZZ) are abnormally liable to develop emphysema, but it is uncertain whether those with partial alpha1AT deficiency (phenotypes Pi MS and MZ) are similarly susceptible. This study was undertaken to determine the frequency of the various Pi phenotypes in a working population in Northern Ireland and to compare the performance of simple pulmonary function tests and prevalence of respiratory symptoms and chest illness between different phenotypes. The population sample consisted of 1995 working men and women aged between 35 and 70 years. The MRC Questionnaire (1966) was used to assess respiratory symptoms, a forced expiratory spirogram was recorded, and a blood sample was analysed for alpha1AT phenotype by acid starch gel electrophoresis and antigen-antibody crossed electrophoresis in every case. The percentage frequencies of the alpha1AT phenotypes were: Pi MM 86-5; MS 7-97; MZ 3-86; IM 0-6; FM 0-4; SZ 0-25; M 0-15; SS 0-1; Z 0-05; MP 0-05; FS 0-05. Respiratory symptoms and a history of previous chest illness occurred with similar frequency among the Pi M, MS, and MZ phenotypes, and a comparison of the regression coefficients for FEV1, FVC, and MMF on age for each phenotype group showed no significant differences between them overall, or when subdivided according to smoking habits or dust exposure. These findings provide no evidence that individuals of phenotype Pi MS or MZ are more than usually liable to develop chronic airways obstruction.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 781898      PMCID: PMC470377          DOI: 10.1136/thx.31.2.149

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  21 in total

1.  PULMONARY EMPHYSEMA AND ALPHA1-ANTITRYPSIN DEFICIENCY.

Authors:  S ERIKSSON
Journal:  Acta Med Scand       Date:  1964-02

2.  BYSSINOSIS AND OTHER RESPIRATORY SYMPTOMS IN FLAX WORKERS IN NORTHERN IRELAND.

Authors:  P C ELWOOD; J PEMBERTON; J D MERRETT; G C CAREY; I R MCAULAY
Journal:  Br J Ind Med       Date:  1965-01

3.  Lung function in alpha1-antitrypsin heterozygotes (Pi type MZ).

Authors:  D M Cooper; V Hoeppner; D Cox; N Zamel; A C Bryan; H Levison
Journal:  Am Rev Respir Dis       Date:  1974-12

Review 4.  Alpha-1-antitrypsin deficiency and pulmonary emphysema: the role of proteolytic enzymes and their inhibitors.

Authors:  D C Hutchison
Journal:  Br J Dis Chest       Date:  1973-07

5.  Pathophysiology of hereditary emphysema.

Authors:  P M Stevens; V S Hnilica; P C Johnson; R L Bell
Journal:  Ann Intern Med       Date:  1971-05       Impact factor: 25.391

6.  Smoking and chronic obstructive lung disease in alpha-1-antitrypsin deficiency.

Authors:  C Mittman; J Lieberman; F Marasso; A Miranda
Journal:  Chest       Date:  1971-09       Impact factor: 9.410

7.  Serum Pi types in patients with pulmonary diseases.

Authors:  M K Fagerhol; H E Hauge
Journal:  Acta Allergol       Date:  1969-05

8.  Heterozygous and homozygous alpha1-antitrypsin deficiency in patients with pulmonary emphysema.

Authors:  J Lieberman
Journal:  N Engl J Med       Date:  1969-08-07       Impact factor: 91.245

9.  Screening for homozygous and heterozygous alpha 1-antitrypsin deficiency. Protein electrophoresis on cellulose acetate membranes.

Authors:  J Lieberman; C Mittman; A S Schneider
Journal:  JAMA       Date:  1969-12-15       Impact factor: 56.272

10.  Antitrypsin deficiency in pulmonary disease: the significance of intermediate levels.

Authors:  M H Welch; M E Reinecke; J F Hammarsten; C A Guenter
Journal:  Ann Intern Med       Date:  1969-09       Impact factor: 25.391

View more
  10 in total

1.  Alpha1-antitrypsin phenotypes and lung function in a moderately polluted northern Ontario community.

Authors:  D N Ostrow; J Manfreda; T Dorman; R M Cherniack
Journal:  Can Med Assoc J       Date:  1978-03-18       Impact factor: 8.262

2.  Respiratory symptoms and pulmonary function in 871 miners according to Pi phenotype: a longitudinal study.

Authors:  F Pierre; Q T Pham; J M Mur; N Chau; J P Martin
Journal:  Eur J Epidemiol       Date:  1988-03       Impact factor: 8.082

3.  Cockayne's syndrome and emphysema.

Authors:  M Cunningham; S Godfrey; W M Moffat
Journal:  Arch Dis Child       Date:  1978-09       Impact factor: 3.791

4.  Assessment of alpha-1-antitrypsin deficiency heterozygosity as a risk factor in the etiology of emphysema. Physiological comparison of adult normal and heterozygous protease inhibitor phenotype subjects from a random population.

Authors:  D J McDonagh; S P Nathan; R J Knudson; M D Lebowitz
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

5.  Alpha, antitrypsin phenotypes in patients with rheumatoid arthritis: a comparison of phenotyping techniques.

Authors:  G Blundell; M Lockhart; M W Boyd; D Merrett; R B Cole
Journal:  Ir J Med Sci       Date:  1980-04       Impact factor: 1.568

6.  Quantum proteolysis by neutrophils: implications for pulmonary emphysema in alpha 1-antitrypsin deficiency.

Authors:  E J Campbell; M A Campbell; S S Boukedes; C A Owen
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

7.  Lung distensibility and airway function in intermediate alpha 1-antitrypsin deficiency (Pi MZ).

Authors:  S F Tattersall; R P Pereira; D Hunter; G Blundell; N B Pride
Journal:  Thorax       Date:  1979-10       Impact factor: 9.139

8.  Pulmonary emphysema associated with the FZ alpha 1-antitrypsin phenotype.

Authors:  D W Cockcroft; R K Tennent; S L Horne
Journal:  Can Med Assoc J       Date:  1981-03-15       Impact factor: 8.262

Review 9.  Chronic obstructive pulmonary disease in alpha1-antitrypsin PI MZ heterozygotes: a meta-analysis.

Authors:  C P Hersh; M Dahl; N P Ly; C S Berkey; B G Nordestgaard; E K Silverman
Journal:  Thorax       Date:  2004-10       Impact factor: 9.139

10.  Alpha 1 antitrypsin and lung function in British coalminers.

Authors:  J E Boyd; P Collings; P M Crofton; G Blundell; J M Davis
Journal:  Br J Ind Med       Date:  1984-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.